BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769
10 results:

  • 1. Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer.
    Wei C; Ma Y; Wang F; Chen Y; Liao Y; Zhao B; Zhao Q; Tang D
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15561-15572. PubMed ID: 37648811
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A CGA/EGFR/gata2 positive feedback circuit confers chemoresistance in gastric cancer.
    Cao T; Lu Y; Wang Q; Qin H; Li H; Guo H; Ge M; Glass SE; Singh B; Zhang W; Dong J; Du F; Qian A; Tian Y; Wang X; Li C; Wu K; Fan D; Nie Y; Coffey RJ; Zhao X
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289315
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.
    Wu C; Li Z; Feng G; Wang L; Xie J; Jin Y; Wang L; Liu S
    Bioengineered; 2021 Dec; 12(1):8378-8395. PubMed ID: 34592889
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced gastric cancer: An International Propensity Score-Matched Study.
    Yan Y; Yang A; Lu L; Zhao Z; Li C; Li W; Chao J; Liu T; Fong Y; Fu W; Woo Y
    Ann Surg Oncol; 2021 Mar; 28(3):1428-1436. PubMed ID: 32862371
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aberrant gata2 epigenetic dysregulation induces a gata2/GATA6 switch in human gastric cancer.
    Song SH; Jeon MS; Nam JW; Kang JK; Lee YJ; Kang JY; Kim HP; Han SW; Kang GH; Kim TY
    Oncogene; 2018 Feb; 37(8):993-1004. PubMed ID: 29106391
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. p38 and JNK pathways control E-selectin-dependent extravasation of colon cancer cells by modulating miR-31 transcription.
    Zhong L; Simoneau B; Huot J; Simard MJ
    Oncotarget; 2017 Jan; 8(1):1678-1687. PubMed ID: 27926494
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HMGB3 characterization in gastric cancer.
    Gong Y; Cao Y; Song L; Zhou J; Wang C; Wu B
    Genet Mol Res; 2013 Dec; 12(4):6032-9. PubMed ID: 24338397
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.
    Grau JJ; Caballero M; Monzó M; Muñoz-García C; Domingo-Domenech J; Navarro A; Conill C; Campayo M; Bombí JA
    J Surg Oncol; 2008 Aug; 98(2):130-4. PubMed ID: 18537153
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [En bloc esophagectomy--when should the digestive tract be reconstructed?].
    Siewert JR; Bartels H; Lange J; Roder JD; Hölscher AH
    Langenbecks Arch Chir; 1990; 375(3):166-70. PubMed ID: 2192212
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Squamous metaplasia with reserve cell hyperplasia in the esophagogastric junction zone.
    Takubo K
    Acta Pathol Jpn; 1981 May; 31(3):349-59. PubMed ID: 7270146
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.